Neuravi picks up $21 mln Series B
Irish stroke therapy platform provider Neuravi has closed $21 million in Series B funding. Life Sciences Partners led the round with participation from return backers Fountain Healthcare Partners, Delta Partners and the Western Development Commission. In conjunction with the funding, Anne Portwich and René Kuijten have been added to Neuravi’s board of directors.
17 June 2015•5 mins read
